Innovation is at the heart of what we do; it is fueled by curiosity and a passionate desire to have a significant impact on underserved communities across the globe. We believe that the ability to listen to and embrace diverse ideas is essential to the innovation that benefits a broader section of society.
Addressing diseases in underserved communities
We continue to shape the global health agenda, broaden patient reach and extend our decades-long efforts to combat diseases in underserved communities. 了解更多
临床试验多样性
It is critical that our innovative therapies include an understanding of impact across a diversity of patient groups, including underserved communities who could greatly benefit from these treatments. That’s why we remain committed to increasing patient diversity within our clinical research and development programs. This includes leveraging data and digital technology to increase understanding and to inform trial design, 审判管理, 病人和地点的选择. 了解更多
全国十大赌博官网制药 is committed to promoting racial equity both inside and outside the company. In 2021, we announced a 10-year collaboration with 26 historically Black colleges, universities and medical schools in the US to address the causes of disparity in healthcare.
In 2022, we committed an additional USD 17.7 million to our Beacon of Hope initiative, bringing total funding to more than USD 50 million over ten years. The additional funds are being used to create Clinical Trial Centers of Excellence at three historically Black medical colleges and universities – Howard University College of Medicine, Meharry Medical College and Charles R. Drew University of Medicine and Science – in addition to centers at the Morehouse School of Medicine announced in 2021. 了解更多
供应商的多样性
We are also working to strengthen our third party and supplier diversity programs. 例如, our Preferred Firm Program for Legal Services now requires specific diverse staffing commitments for each engagement. We have developed LGBTQI guidance for third parties and uphold human rights and DEI principles in – our third party risk management, procurement and supply chain practices.